Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules

Thyroid

Volumn 15, Issue 4, 2005, Pages 389-397

  Gozu, Hulya ^a,d   Avsar, Melike ^a   Bircan, Rifat ^a   Claus, Maren ^b   Sahin, Serap ^a   Sezgin, Ozlem ^c   Deyneli, Oguzhan ^a   Paschke, Ralf ^b   Cirakoglu, Beyazit ^a   Akalin, Sema ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c SSK Goztepe Hospital   (Turkey)

^d Gayrettepe   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROPYLTHIOURACIL; THYROTROPIN RECEPTOR;

ADULT; ANIMAL CELL; CASE REPORT; CONFERENCE PAPER; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; LEUKOCYTE; MALE; NODULAR GOITER; NONHUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECEPTOR GENE; SCINTIGRAPHY; SITE DIRECTED MUTAGENESIS; SUBTOTAL THYROIDECTOMY; WILD TYPE;

ADULT; FEMALE; HUMANS; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, THYROTROPIN; THYROID NODULE;

EID: 21044452151     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.389     Document Type: Conference Paper

References (43)

1. Paschke R 1996 Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism. Exp Clin Endocrinol Diabetes 104(Suppl 4):129-132.
2. Takeshita A, Nagayama Y, Yokoyama N, Ishkawa N, Ito K, Yamashita T, Obara T, Murakami Y, Kuma K, Takamatsu J, Ohsawa N, Nagataki S 1995 Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J Clin Endocrinol Metab 8:2607-2611.
3. Siegel RD, Lee SL 1998 Toxic nodular goiter. Toxic adenoma and toxic multinodular goiter. Endocrinol Metab Clin North Am 27:151-168.
4. Russo D, Arturi F, Chiefari E, Filetti S 1997 Molecular insights into TSH receptor abnormality and thyroid disease. J Endocrinol Invest 20:36-47.
5. Bodenner DL, Lash RW 1998 Thyroid disease mediated by molecular defects in cell surface and nuclear receptors. Am J Med 105:524-538.
6. Krohn K, Paschke R 2002. Somatic mutations in thyroid nodular disease. Mol Genet Metab 75:202-208.
7. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651.
8. Fuhrer D, Lachmund P, Nebel IT, Paschke R 2003 The thyrotropin receptor mutation database: Update 2003. Thyroid 13:1123-1126.
9. Ahmad MF, Stenszky F, Juhazs F, Balazs G, Farid NR 1994 No mutations in the translated region of exon 1 in the TSH receptor in Graves' thyroid glands. Thyroid 4:151-153.
10. John SW, Weitzner G, Rozen R, Scriver CR 1991 A rapid procedure for extracting genomic DNA from leucocytes. Nucleic Acids Res 19:408.
11. Spambalg D, Sharifi N, Elisei R, Gross JL, Medeiros-Neto G, Fagin JA 1996 Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: Low prevalence of mutations predicts infrequent involvement in malignant transformation. J Clin Endocrinol Metab 81:3898-3901.
12. Krohn K, Wohlgemuth S, Gerber H, Paschke R 2000 Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations. J Pathol 192:37-42.
13. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T 1989 Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770.
14. Higuchi R 1989 Using PCR to engineer DNA. In: Erlich HA (eds) PCR Technology. Stockton Press, New York; pp. 61-70.
15. Libert F, Lefort A, Gerard C, Parmentier M, Perret J, Ludgate M, Dumont JE, Vassart G 1989 Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: Evidence for binding of autoantibodies. Biochem Biophys Res Commun 165:1250-1255.
16. Wonerow P, Schoneberg T, Schultz G, Gudermann T, Paschke R 1998 Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation. J Biol Chem 273:7900-7905.
17. Berridge MJ 1983 Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem J 212:849-858.
18. Swillens S 1995 Interpretation of binding curves obtained with high receptor concentrations: Practical aid for computer analysis. Mol Pharmacol 47:1197-1203.
19. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, McCormick F 1990 Two G protein oncogenes in human endocrine tumors. Science 249:655-659.
20. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog 4:345-349.
21. s alpha genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 82:2695-2701.
22. Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, DuVillard JA, Caillou B, Monier R, Rapoport B, Filetti S, Suarez HG 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 80:1347-1351.
23. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, Fuhrer D, Paschke R 2001 Detection of thyroid-stimulating hormone receptor and Gs alpha mutations in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 78:684-691.
24. Vanvooren V, Uchino S, Duprez L, Costa MJ, Vandekerckhove J, Parma J, Vassart G, Dumont JE, Van Sande J, Noguchi S 2002 Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population. Eur J Endocrinol 147:287-291.
25. Georgopoulos NA, Sykiotis GP, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Papavassiliou AG, Vagenakis AG 2003 Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway. Eur J Endocrinol 149:287-292.
26. s alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885-3891.
27. Nogueira CR, Kopp P, Arseven OK, Santos CL, Jameson JL, Medeiros-Neto G 1999 Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil. Thyroid 9:1063-1068.
28. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 79:1785-1789.
29. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J Clin Endocrinol Metab 79:657-661.
30. Russo D, Arturi F, Suarez HG, Schlumberger M, Du Villard JA, Crocetti U, Filetti S 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 81:1548-1551.
31. Tonacchera M, Chiovato L, Pinchera A, Agretti P, Fiore E, Cetani F, Rocchi R, Viacava P, Miccoli P, Vitti P 1998 Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma. J Clin Endocrinol Metab 83:492-498.
32. Tassi V, Di Cerbo A, Porcellini A, Papini E, Cisternino C, Crescenzi A, Scillitani A, Pizzuti A, Ratti A, Trischitta V, Avvedimento VE, Fenzi G, De Filippis V 1999 Screening of thyrotropin receptor mutations by fine-needle aspiration biopsy in autonomous functioning thyroid nodules in multinodular goiters. Thyroid 9:353-357.
33. Holzapfel HP, Fuhrer D, Wonerow P, Weinland G, Scherbaum WA, Paschke R 1997 Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. J Clin Endocrinol Metab 82:4229-4233.
34. Tonacchera M, Agretti P, Chiovato L, Rosellini V, Ceccarini G, Perri A, Viacava P, Naccarato AG, Miccoli P, Pinchera A, Vitti P 2000 Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. J Clin Endocrinol Metab 85:2270-2274.
35. Trulzsch B, Krohn K, Wonerow P, Paschke R 1999 DGGE is more sensitive for the detection of somatic point mutations than direct sequencing. Biotechniques 27:266-268.
36. Vassart G 1997 New pathophysiological mechanisms for hyperthyroidism. Horm Res 48(Suppl 4):47-50.
37. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G 1995 Genetic basis of endocrine disease. Somatic and germline mutations of the TSH Receptor gene in thyroid diseases. J Clin Endocrinol Metab 80:2577-2585.
38. Tonacchera M, Van Sande J, Parma J, Duprez L, Cetani F, Costagliola S, Dumont JE, Vassart G 1996 TSH receptor and disease. Clin Endocrinol 44:621-633.
39. Wonerow P, Neumann S, Guderman T, Paschke R 2001 The thyrotropin receptor mutations as a tool to understand thyrotropin receptor action. J Mol Med 79:707-721.
40. Fuhrer D, Wonerow P, Willgerodt H, Paschke R 1997 Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 82:4234-4238.
41. Kopp P, van Sande J, Parma J, Duprez L, Gerber H, Joss H, Jameson JL, Dumont JE, Vassart G 1995 Brief report: Congenital hyperthyroidism caused by a mutation in the TSHR gene. N Engl J Med 332:150-154.
42. Kopp P, Jameson JL, Roe TF 1997 Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene. Thyroid 7:765-770.
43. Fuhrer D, Lewis MD, Alkhafaji F, Starkey K, Paschke R, Wynford-Thomas D, Eggo M, Ludgate M 2003 Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context. Endocrinology 144:4018-4030.